UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Explore effective ways to generate income in just 5 days. Learn practical strategies that can help you boost your earnings quickly.
17,322 articlesUBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
In 2022, the S&P 500 plunged while a healthcare-focused ETF held its ground better than most. This story examines why...
As markets digest a potential shift in leadership, the biggest test for any Fed chair may be broader than inflation. ...
BingEx reports Q1 2026 results that reveal both momentum and headwinds. This article breaks down the key numbers, exp...
A boutique fund revealed a sizable stake in a hotel stock, signaling interest in the sector’s recovery. Here’s a prac...
A major fund took a $61 million stake in a leading self-storage REIT just as a blockbuster $10.5 billion deal was win...
Private credit has grown rapidly, bringing yield and risk in equal measure. This article breaks down what JPMorgan Ch...
Starting a portfolio in AI is daunting but doable. This guide lays out practical trades you could make today, with co...
As Costco prepares to report Q4 results, investors weigh whether costco wholesale corp's stock deserves a spot in the...
A clear look at a Vanguard mega-cap ETF with a heavy tilt toward four tech giants, what that means for risk and retur...
New data indicate that small investors are expanding their footprint in single-family rentals, lifting rents and comp...
A fresh, reader-friendly breakdown of Chagee's Q1 2026 earnings. We unpack revenue drivers, margins, and guidance to ...